» Articles » PMID: 22632064

Pharmacokinetics of Dexamethasone Following Intra-articular, Intravenous, Intramuscular, and Oral Administration in Horses and Its Effects on Endogenous Hydrocortisone

Overview
Specialty Pharmacology
Date 2012 May 29
PMID 22632064
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

This study investigated and compared the pharmacokinetics of intra-articular (IA) administration of dexamethasone sodium phosphate (DSP) into three equine joints, femoropatellar (IAS), radiocarpal (IAC), and metacarpophalangeal (IAF), and the intramuscular (IM), oral (PO) and intravenous (IV) administrations. No significant differences in the pharmacokinetic estimates between the three joints were observed with the exception of maximum concentration (Cmax ) and time to maximum concentration (Tmax ). Median (range) Cmax for the IAC, IAF, and IAS were 16.9 (14.6-35.4), 23.4 (13.5-73.0), and 46.9 (24.0-72.1) ng/mL, respectively. The Tmax for IAC, IAF, and IAS were 1.0 (0.75-4.0), 0.62 (0.5-1.0), and 0.25 (0.08-0.25) h, respectively. Median (range) elimination half-lives for IA and IM administrations were 3.6 (3.0-4.6) h and 3.4 (2.9-3.7) h, respectively. A 3-compartment model was fitted to the plasma dexamethasone concentration-time curve following the IV administration of DSP; alpha, beta, and gamma half-lives were 0.03 (0.01-0.05), 1.8 (0.34-2.3), and 5.1 (3.3-5.6) h, respectively. Following the PO administration, the median absorption and elimination half-lives were 0.34 (0.29-1.6) and 3.4 (3.1-4.7) h, respectively. Endogenous hydrocortisone plasma concentrations declined from a baseline of 103.8 ± 29.1-3.1 ± 1.3 ng/mL at 20.0 ± 2.7 h following the administration of DSP and recovered to baseline values between 96 and 120 h for IV, IA, and IM administrations and at 72 h for the PO.

Citing Articles

Effect of dexamethasone on antibody response of horses to vaccination with a combined equine influenza virus and equine herpesvirus-1 vaccine.

Kreutzfeldt N, Chambers T, Reedy S, Spann K, Pusterla N J Vet Intern Med. 2023; 38(1):424-430.

PMID: 38141173 PMC: 10800231. DOI: 10.1111/jvim.16978.


Evaluation of the effect of glucocorticoid treatment on adrenocortical functions by monitoring endogenous hydrocortisone in horses.

Kikuchi M, Nagata S, Ishige T, Minamijima Y, Hirota K, Tozaki T J Vet Med Sci. 2023; 85(6):647-652.

PMID: 37150610 PMC: 10315556. DOI: 10.1292/jvms.23-0011.


Measurements of hydrocortisone and cortisone for longitudinal profiling of equine plasma by liquid chromatography-tandem mass spectrometry.

Tou K, Cawley A, Bowen C, Sornalingam K, Fu S Drug Test Anal. 2022; 14(5):943-952.

PMID: 35195373 PMC: 9545025. DOI: 10.1002/dta.3244.


Across-species meta-analysis of dexamethasone pharmacokinetics utilizing allometric and scaling modeling approaches.

Song D, Jusko W Biopharm Drug Dispos. 2021; 42(5):191-203.

PMID: 33638217 PMC: 8859844. DOI: 10.1002/bdd.2266.


Biomaterial strategies for improved intra-articular drug delivery.

Mancipe Castro L, Garcia A, Guldberg R J Biomed Mater Res A. 2020; 109(4):426-436.

PMID: 32780515 PMC: 8906235. DOI: 10.1002/jbm.a.37074.